News | Pfizer | Pfizer

Home
News

Thrive with Pride

Pfizer is honored to share the 16th anniversary edition of our Pride Journal - a platform where our LGBTQ+ Pfizer Colleagues and allies can share personal experiences of struggles, triumph, and their hope for the future in honor of Pride Month.

Our Purpose

Fake Drugs 101: Facts on Illegal, Counterfeit Drugs

Get the basics on fake drugs. What exactly are counterfeit drugs? How big is the counterfeit drug problem? And who's at risk?

Your Health

8 Common STDs: What You Need to Know

Knowing what to look out for can help you address STDs before they cause long-term harm to the individual or spread within a community. Here’s what you need to know about eight common STDs.

Search More Stories

Behind the Science Features

Experience multimedia stories that give you an exciting view of Pfizer’s initiatives as we pursue breakthroughs that change patients’ lives.

Go Behind the Science

Media Resources

This information is intended for media professionals. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Pipeline Snapshot as of May 3, 2022

00Phase 1
00Phase 2
00Phase 3
00Registration
00Total

Download Complete Pipeline PDF

Clinical Trials

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Go to Pfizer Clinical Trials Site

Our Careers

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to improve healthcare around the world.

Explore Our Careers

To Our Investors

Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.

To Our Investors

Stay Informed. Knowledge is Power.

Thrive with Pride

Fake Drugs 101: Facts on Illegal, Counterfeit Drugs

8 Common STDs: What You Need to Know

Experience multimedia stories that give you an exciting view of Pfizer’s initiatives as we pursue breakthroughs that change patients’ lives.

June 2022

Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts

Valneva and Pfizer Announce Closing of Equity Investment

Pfizer Declares Third-Quarter 2022 Dividend

Statement by Pfizer Chairman and CEO Albert Bourla to Pfizer Colleagues

Truveta Announces Strategic Collaboration with Pfizer to Accelerate Safety Insights in Real Time

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age

Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain

Pfizer and BioNTech Provide Update on Rolling Submission to European Medicines Agency for a Potential Variant-Adapted Vaccine

Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA

Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47

Pfizer Completes Acquisition of ReViral

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to improve healthcare around the world.

Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.

Why Invest

Financial Reports

Events and Presentations

Stock Information

Investor News

Investor Insights

Shareholder Services